152 related articles for article (PubMed ID: 8734491)
1. (-)-pindolol and (+/-)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors.
Assie MB; Koek W
Neuropharmacology; 1996 Feb; 35(2):213-22. PubMed ID: 8734491
[TBL] [Abstract][Full Text] [Related]
2. Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study.
Gartside SE; Clifford EM; Cowen PJ; Sharp T
Br J Pharmacol; 1999 May; 127(1):145-52. PubMed ID: 10369467
[TBL] [Abstract][Full Text] [Related]
3. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
Gobert A; Millan MJ
Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
[TBL] [Abstract][Full Text] [Related]
4. (-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain.
Jolas T; Haj-Dahmane S; Lanfumey L; Fattaccini CM; Kidd EJ; Adrien J; Gozlan H; Guardiola-Lemaitre B; Hamon M
Naunyn Schmiedebergs Arch Pharmacol; 1993 May; 347(5):453-63. PubMed ID: 7686633
[TBL] [Abstract][Full Text] [Related]
5. Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n-propylamino)tetralin in awake cats.
Fornal CA; Martin FJ; Metzler CW; Jacobs BL
J Pharmacol Exp Ther; 1999 Oct; 291(1):229-38. PubMed ID: 10490909
[TBL] [Abstract][Full Text] [Related]
6. Anxiolytic effects in the plus-maze of 5-HT1A-receptor ligands in dorsal raphé and ventral hippocampus.
File SE; Gonzalez LE
Pharmacol Biochem Behav; 1996 May; 54(1):123-8. PubMed ID: 8728549
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis.
Sharp T; Bramwell SR; Hjorth S; Grahame-Smith DG
Br J Pharmacol; 1989 Nov; 98(3):989-97. PubMed ID: 2574066
[TBL] [Abstract][Full Text] [Related]
8. Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain.
Waldmeier PC; Williams M; Baumann PA; Bischoff S; Sills MA; Neale RF
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):609-20. PubMed ID: 2905765
[TBL] [Abstract][Full Text] [Related]
9. In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol.
Hjorth S; Sharp T
J Pharmacol Exp Ther; 1993 May; 265(2):707-12. PubMed ID: 8098761
[TBL] [Abstract][Full Text] [Related]
10. The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo.
Sharp T; McQuade R; Fozard JR; Hoyer D
Br J Pharmacol; 1993 Jul; 109(3):699-702. PubMed ID: 8102935
[TBL] [Abstract][Full Text] [Related]
11. Assessment of relative efficacies of 5-HT1A receptor ligands by means of in vivo animal models.
Sánchez C; Arnt J; Moltzen E
Eur J Pharmacol; 1996 Nov; 315(3):245-54. PubMed ID: 8982661
[TBL] [Abstract][Full Text] [Related]
12. cis-(+)-8-OH-1-CH3-DPAT, (+)ALK-3, a novel stereoselective pharmacological probe for characterizing 5-HT release-controlling 5-HT1A autoreceptors. An in vivo brain microdialysis study.
Hjorth S; Sharp T; Liu Y
Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):149-57. PubMed ID: 1692973
[TBL] [Abstract][Full Text] [Related]
13. Studies on the role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release--I. BMY7378 and prazosin.
Hjorth S; Bengtsson HJ; Milano S; Lundberg JF; Sharp T
Neuropharmacology; 1995 Jun; 34(6):615-20. PubMed ID: 7566497
[TBL] [Abstract][Full Text] [Related]
14. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.
Sharp T; Backus LI; Hjorth S; Bramwell SR; Grahame-Smith DG
Eur J Pharmacol; 1990 Feb; 176(3):331-40. PubMed ID: 1970304
[TBL] [Abstract][Full Text] [Related]
15. Antagonism by pindolol, but not betaxolol, of 8-OH-DPAT-induced facilitation of male rat sexual behavior.
Ahlenius S; Larsson K
J Neural Transm; 1989; 77(2-3):163-70. PubMed ID: 2569497
[TBL] [Abstract][Full Text] [Related]
16. Effects of tertatolol, a beta-adrenoceptor antagonist with agonist affinity at 5-HT1A receptors, in an animal model of migraine: comparison with propranolol and pindolol.
Saxena PR; Heiligers JP; Villalón CM; Ferrari MD
Eur J Pharmacol; 1992 Sep; 220(1):79-86. PubMed ID: 1358648
[TBL] [Abstract][Full Text] [Related]
17. Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study.
Gur E; Lerer B; Newman ME
J Neural Transm (Vienna); 1997; 104(8-9):795-804. PubMed ID: 9451712
[TBL] [Abstract][Full Text] [Related]
18. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
19. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181.
Hillegaart V; Ahlenius S
Br J Pharmacol; 1998 Dec; 125(8):1733-43. PubMed ID: 9886765
[TBL] [Abstract][Full Text] [Related]
20. BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex.
Borsini F; Ceci A; Bietti G; Donetti A
Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):283-90. PubMed ID: 8584043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
